Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab and Trifluridine-Tipiracil in Metastatic Colorectal Cancer
NCT05468892Phase 2Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Oct 2019
- Primary completion
- May 2022
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in metastatic colorectal cancer (mCRC), sponsored by University of Campania Luigi Vanvitelli. Started Oct 2019; status: completed.
02
Drugs
panitumumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT05468892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05468892.